Pain Patch

Settling antitrust claims with the state of California on Friday, pharmaceutical company Endo agreed to pay $760,000 and not strike deals with generic drugmakers without state approval as it did to delay a generic version of its Lidoderm pain patch in 2012.

SAN FRANCISCO – Settling antitrust claims with the state of California on Friday, pharmaceutical company Endo agreed to pay $760,000 and not strike deals with generic drugmakers without state approval as it did to delay a generic version of its Lidoderm pain patch in 2012.

Categories / Business, Courts

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.